PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 5.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $427,193 | – | 193,300 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
| Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
| Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
| GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
| Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
| Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
| Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
| Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
| Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |